| Literature DB >> 31261958 |
Giuseppe Sferrazzo1, Rosa Palmeri2, Luca Vanella1, Lucia Parafati2, Simone Ronsisvalle1, Antonio Biondi3, Francesco Basile3, Giovanni Li Volti4,5, Ignazio Barbagallo1.
Abstract
Natural bioactive compounds may be used in obese patients because of their ability to impact on various key mechanisms involved in the complex pathophysiological mechanisms of such condition. The aim of this study was to investigate the effect of a Mangifera indica L. leaf extract (MLE) on adipogenic differentiation of murine preadipocyte cells. 3T3-L1 cells were treated during their differentiation with various concentrations of (Mangifera indica L.) leaves extract (MLE) (750, 380, 150, 75 and 35 μg) in order to assess their lipid content, adiponectin production, expression profile of genes involved in lipid metabolism, oxidative stress and inflammation. Our results showed that MLE was particularly enriched in polyphenols (46.30 ± 0.083 mg/g) and that pharmacological treatment of cells resulted in a significant increase of adiponectin levels and reduction of intracellular lipid content. Consistently with these results, MLE resulted in a significant decrease of the expression of genes involved in lipid metabolism (FAS, PPARG, DGAT1, DGAT2, and SCD-1). In conclusion, our results suggest that MLE may represent a possible pharmacological tool for obese or metabolic syndrome patients.Entities:
Keywords: adipocyte; adiponectin; mangiferin; metabolic syndrome; oxidative stress
Mesh:
Substances:
Year: 2019 PMID: 31261958 PMCID: PMC6651838 DOI: 10.3390/ijms20133211
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Methodology of evaluations and biological samples preparations are reported in a previous work (ng/mL ± standard deviation, r2, limit of detection (LOD) and LOQ) [18].
| Compounds | Concentration (ng/mL) | LOD | LOQ |
|
|---|---|---|---|---|
| Mangiferin | 70,200 ±150 | 1875 | 7320 | 0.9985 |
| Myo-inositol | 21,600 ± 230 | 832 | 4250 | 0.9973 |
| γ-Orizanolo | 47,700 ± 190 | 1432 | 5265 | 0.9987 |
Figure 1In vitro antioxidant activity measured through percentage of DPPH Inhibition.
Figure 2The viability assay in 3T3-L1 cells measured by bromide 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay. Bars represent the mean ± SEM of six independent experiments. * p < 0.05 versus control (CTRL) cells.
Figure 3Inhibition of α-glucosidase through MLE. The IC50 values were graphically determined as the half-maximal inhibitory concentration of the inhibitor species giving 50% inhibition. All assays were performed in triplicate.
Figure 4Analysis of adipogenic differentiation in 3T3-L1 cells. Images (A–C) microscopy are of cells after differentiation. Oil red staining in undifferentiated cells (A), differentiated cells (B) and differentiated + MLE (C). In Figure (D); quantitative oil red staining measured by spectrophotometer at 490 nm reading. Images (E–I), show a quantitative analysis of gene expression of FAS (E), PPARγ (F), DGAT1 (G), DGAT2 (H) and SCD1 (I) after adipogenic differentiation. Bars represent the mean ± SD of six independent experiments. * p < 0.05 versus undifferentiated cells; ** p < 0.05 versus differentiated cells.
Figure 5Glutathione cellular content after adipogenic differentiation. Bars represent the mean ± SEM of six independent experiments. * p < 0.05 versus undifferentiated cells; ** p < 0.05 versus differentiated cells.
Figure 6Gene expression CAT (A), MnSOD (B), IL-6 (C) and IL-10 (D) evaluated by RT-PCR. Bars represent the mean ± SEM of six independent experiments. * p < 0.05 versus undifferentiated cells; ** p < 0.05 versus differentiated cells.
Figure 7Gene expression of PPAR-α (A), HO-1 (B) and adiponectin (C) evaluated by RT-PCR. In image (D) protein adiponectin cellular levels and in (E) protein adiponectin released in cell culture supernatant tested by enzyme-linked immunosorbent assay (ELISA). Bars represent the mean ± SEM of six independent experiments. * p < 0.05 versus undifferentiated cells; ** p < 0.05 versus differentiated cells.
Primers used in this study.
| Gene GenBank Code | Forward and Reverse Primers Sequence (5′→3′) | Tm °C | Amplicon Size |
|---|---|---|---|
| GAAGCCGCTTATGTGTATCGC | 61.5 | 76 | |
| GAATGGGTACATTGGGAACAGT | 60.0 | ||
| AAGATTGCCTTCTCCGGGTG | 60.04 | 430 | |
| TGTGGAGAATCGAACGGCAA | 59.97 | ||
| GTTTCCGTCCAGGGTGGTAG | 287 | 871 | |
| GTTGGATCAGCCCCACTTGA | 1119 | ||
| CAGGTGCCGTCTTGGGTTAT | 1932 | 100 | |
| CAGGAGGATATGCGCCAGAG | 1993 | ||
| GGAGGTGGTGATAGCCGGTAT | 62.9 | 140 | |
| TGGGTAATCCATAGAGCCCAG | 60.4 | ||
| AGCTTCGGCACATATTTCATCTG | 61.0 | 89 | |
| CGTTCACTCCCATGACAAACA | 60.5 | ||
| CCTCACAGATGGCGTCACTT | 840 | 200 | |
| TGGGGGCCAGTATTGCATTT | 1001 | ||
| GCTGGACAACATACTGCTAACC | 60.9 | 78 | |
| ATTTCCGATAAGGCTTGGCAA | 60.0 | ||
| CCCCAATTTCCAATGCTCTCC | 598 | 141 | |
| CGCACTAGGTTTGCCGAGTA | 699 | ||
| GCCCAAACCTATCGTGTCCA | 3102 | 70 | |
| AGGGAACCCTAAATGCTGCC | 3133 | ||
| CCGAACATTGGTGTTCGCAG | 135 | 161 | |
| AGATACGCCCAAATGCACCA | 257 | ||
| TCGCTGATGCACTGCCTATG | 62.4 | 103 | |
| GAGAGGTCCACAGAGCTGATT | 60.9 | ||
| GAGTAGCTGAGCTTTGGGCT | 1378 | 591 | |
| ACTTCATCAGCGGGGACTTG | 1930 |